JPRN-UMIN000003613已完成未知
Cancer vaccine in combination with down-modulation of regulatory T cells for patients with incurable cancer - SimVac
Department of Clinical Oncology, Kawasaki Medical School0 个研究点目标入组 80 人开始时间: 2010年5月14日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Autoimmune disease Uncontrollable complication infection, diabetes, hypertension, ischemic heart disease, cerebral infarction Pregnancy Allergy Interstitial lung disease
研究者
相似试验
未知
1 期
Cancer vaccination therapy by using tumor-associated antigen GPC3-targeted peptide in the partients who have received trans-arterial infusion chemotherapy against advanced hepatocellular carcinoma -A randomized double blind studyhepatocellular carcinomaJPRN-UMIN000001732Department of Gastroenterology and Hepatology, Graduate School of Medical Sciences Kumamoto University20
招募中
2 期
Adjuvant treatment of novel multiple cancer vaccine restricted with HLA-A24 for patients with completely resected non-small cell lung cancer. randomized phase II trialnon-small cell lung cancerJPRN-UMIN000009380Fukushima Medical University60
已完成
1 期
Treatment with cancer peptide vaccine cocktail derived from URLC10, KIF20A, VEGFR-1 and VEGFR-2 for the patients with advanced or recurrent esophageal cancer refractory to the standerd tharapyEsophageal cancerJPRN-UMIN000013709Wakayama Medical University40
已完成
1 期
Tumor specific vaccination therapy for advanced/recurrent ovarian cancer using HLA-A*0201 restricted Specific Epitope Peptides Cocktail derived from Tumor genom/Tumor related Angiogenetic factors genomadvanced/recurrent ovarian cancer with the conditions of unremoval by surgery, or refractory, chemo-resistant disease.JPRN-UMIN000003860Iwate Medical University School of Medicine Department of Obstetrics and Gynecology30
已完成
1 期
Tumor specific vaccination therapy for advanced/recurrent cervical cancer using HLA-A*0201 restricted Specific Epitope Peptides Cocktail derived from Tumor genom/Tumor related Angiogenetic factors genomadvanced/recurrent cervical cancer with the conditions of unremoval by surgery, or refractory, chemo-resistant disease.JPRN-UMIN000003903Iwate Medical University School of Medicine department of Obastetrics and Gynecology30